Total Covid-19 vaccine doses administered in India crosses 20 crore

In a significant landmark, the cumulative COVID-19 vaccine doses administered in the country has crossed 20 crore, the Union health ministry said on Tuesday.

Covid vaccination, vaccine, coronavirus vaccine
A medic administers the dose of vaccine to a beneficiary, at Moti Lal Nehru Medical College vaccination in Prayagraj on Thursday.
Press Trust of India New Delhi
2 min read Last Updated : May 25 2021 | 8:53 PM IST

In a significant landmark, the cumulative COVID-19 vaccine doses administered in the country has crossed 20 crore, the Union health ministry said on Tuesday.

In the age group of 18-44 years, the ministry said, 9,42,796 people received their first vaccine dose on Tuesday, and cumulatively, 1,28,74,546 have received vaccine doses across the country since the start of the phase-3 of the vaccination drive.

Bihar, Rajasthan and Uttar Pradesh have administered to more than 10 lakh beneficiaries in the 18-44 age group their first dose of Covid vaccine, it said.

The country has administered 20,04,94,991 vaccine doses so far, as per the 7 pm provisional report, the ministry said.

The total of 20,04,94,991 includes 97,94,835 healthcare workers (HCWs) who have taken their first dose and 67,28,443 HCWs who have taken their second dose, and 1,51,62,077 frontline workers (FLWs) who have received their first dose, 83,77,270 FLWs who have taken their second dose.

There are 1,28,74,546 people in the 18-44 years age group who have received their first dose.

Besides them, 6,20,47,952 and 1,00,24,157 beneficiaries in the 45-60 years category have been administered their first and second doses respectively, while 5,71,19,900 and 1,83,65,811 beneficiaries above 60 years have taken their first and second doses respectively, the ministry said.

The ministry said that vaccination is an integral pillar of the comprehensive strategy for containment and management of the Covid pandemic, along with test, track, treat and Covid appropriate behaviour.

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, it said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccination

First Published: May 25 2021 | 8:51 PM IST

Next Story